Member Info for bobsson

No because afaik Evgen are not partnering financially with anyone on this trial.

DH1981, Blu and crypto are inextricably linked, on a psychological feel good factor if crypto is doing well so should Blu`s share price. However the fundamental link is that if all thinks crypto are banned by international regulation, and there are some financial and political thinkers who want it banned, then Satoshipay will have to think of another market for its technology. But I don`t think that will happen, crypto is emerging from the "Wild West" phase of its development and will face regulation to bring it into the mainstream of finance. But I think crypto is here to stay and all of what Satoshipay has to offer will provide the links for decentralised finance to link to the mainstream. The major issue for Satoshipay is that its offerings are still in development, we hit the jackpot if they work, but not if they don`t.
Just my view.

Thanks. But at least the process has started.

Time flies, P1 has been enrolled in the trial for around 18 months and P2 for around 12 months. Should have more data on progress of P1 soon.

Thanks Paul. Right on cue. We now have four more patients being treated. So that makes ten in total. One about 15 months in, another 9 months, four at 3 months and 4 just started. If results continue to be impressive, I think because of the numbers of patients involved the FDA would discount any placebo effect and give the green light to a formal Phase 2 trial. I expect go ahead this year with start in 2024, I also expect a major pharma to jump on board in 2023.

For clarity, I can trade my TLSA shares on AJB. However regarding the MS trials whilst it is good the two longer term MS patients are showing stabilsation/improvement, the sample is too small. We need all 10 of the additional patients onto the trial asap. Only 6/10 new patients enrolled so far?

NTD, I very much share your views on what has happened to us ex TILS shareholders. I am able to trade my TLSA shares and wait patiently for the spark to finally ignite the share price. My entitlement to ACUT shares rests in a closed Barclays account so when Accustem finally lists I hope I can have them transferred to AJB for another share in the portfolio. For TLSA share price to reach anywhere near the price I paid for it, let alone the spike I failed to take advantage of, there would have to be real clinical progress and therefore hope of even further big gains.

There are lots of steps needed before the iron ore mine can start exporting material to the port. Therefore there is lots of news due which should be RNSable. We need to start the news flow this month please.

Richard Sneller ups his stake.

Yes. In a previous post I said I had reviewed the portfolio update and Dynasty RNS`s. NAV 0.24p per share on latest (obsolete) valuations of BLU assets of £11.9 million.
Did my conservative (conservative imo) future valuation on Dynasty at £100 million and Satoshipay at £1 billion, other assets £1.1 million. NAV per share 5.9p. If I wanted to be bullish I could double that NAV.

An important item you miss from your list is * sales expansion into new markets.
The medical products appear to be top notch, once you sign your customers up they appear happy and want to stay.

B7, Its a pity your enthusiasm for todays news is not shared by the market. Why not add to over 3% and get your name in lights and perhaps prompt a rise in the share price?
However I do think these appointments are very positive for GILD.

I think there is lots of news due, a lot of administrative, financial, environmental, construction, sub contracting production, port storage confirmation. Does the site production contractor transport the ore to port, or will it use independent sub contractors eg one man and a rig. We could do with a list and tick them off. My target for loaded road trains to port is August 23. Things need to move now.

Just reviewed the RNS Trading Update 28/9/22, and the Dynasty RNS 31/10/22. Appears we should expect more new Dynasty contracts and planned launches this month. Hope so.

Help please. HL state: "WE have now completed the transfer of these shares into Crest". So all ACUT shares allocated to TLSA (TILS) shareholders have not been transferred into Crest it is just HL conducting the exercise on behalf of their clients? If so other nominee share dealing companies should follow HL`s lead. Do any Barclays customers have any ACUT allocation, and have Barclays taken any action to assist?

Thanks to DB on the other board. An interesting read and going to be fantastic if it all works out!

https://pendulum-chain.medium.com/defi-and-traditional-finance-a-match-made-in-heaven-fbcd56ae7e04

PF, Making and taking profits, and avoiding losses is a very sensible strategy.

PF, Do you mean you will sell and buy on the way up? Your timing will need to be very good. This share goes up a lot on news, but one day it might not just slip gently back down. This could easily be 25p at the end of 2023 in my opinion.

Super start to the new year now up around 8%. Looks as if it is the same buyer for the 1 and 1.5 million blocks. Stake building here I think.

Hi ragnarr, Thank you for your input to this bb in 2022. I have a request please. Would you kindly write a review of BLU`s 2022, good and bad, and set out BLU`s milestones for 2023?
TIA